DMD and Becker muscular dystrophy: The bmx mouse provides the first preclinical mouse model of BMD featuring CRISPR-induced deletion of endogenous dystrophin exons 45–47, which models the most common BMD patient mutation and is associated with more severe skeletal muscle pathology and cardiac outcomes.19